Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study

Topiroxostat, a selective xanthine oxidoreductase inhibitor, is used in Japan for the treatment of hyperuricemic patients with or without gout. In terms of the effectiveness of topiroxostat in lowering serum urate levels, the dose–response relationship has been evaluated; however, it remains to be v...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosoya, Tatsuo, Sasaki, Tomomitsu, Ohashi, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323498/
https://www.ncbi.nlm.nih.gov/pubmed/27832384
http://dx.doi.org/10.1007/s10067-016-3474-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323498/
https://www.ncbi.nlm.nih.gov/pubmed/27832384
http://dx.doi.org/10.1007/s10067-016-3474-8

Ejemplares similares